Back

The effect of sex on SGLT-2 antagonists and GLP-1 agonists in the treatment of heart failure: a systematic review and meta-analysis

12 May 2024 (11:00 - 12:00)
Organised by: Logo
Congress Presentation Part of: ePosters in acute heart failure 8 Pharmacotherapy HFA Premium Access Heart Failure 2024 Heart Failure Association (HFA)

About the speaker

Photo
Mr Mevin Philip

(United Kingdom of Great Britain & Northern Ireland)

7 More presentations in this session

Presentation thumbnail
Clinical profile of the elderly patient admitted for acute heart failure in the emergency department of a tertiary hospital
Doctor D. De Almeida Fernandes (Coimbra, PT)
Abstract Slides Video
Presentation thumbnail
Prognostic effect of the combined use of thiazides and loop diuretics at discharge following a hospitalization for acute heart failure
Doctor A. Gasull Sandoval (Valencia, ES)
Abstract Slides Video
Presentation thumbnail
Thoracic fluid content as a marker of high intravenous diuretic requirements in patients hospitalized for heart failure decompensation
Doctor A. Galas (Warsaw, PL)
Abstract Slides Video
Presentation thumbnail
What clinical parameters are associated with the prescription at hospital discharge of all medications with prognostic improvement? Analysis in de novo heart failure with reduced ejection fraction
Doctor R. Lopez Vilella (Valencia, ES)
Abstract Slides Video
Presentation thumbnail
Patiromer in hyperkalemia management: real-world perspective for spironolactone-untreated patients
Doctor F. Gerardo (Amadora, PT)
Abstract Slides Video

Access the full session

Session thumbnail
ePosters in acute heart failure 8

The Event

Event poster

Heart Failure 2024

12 May 2024 11:00 CET
You may be interested in
thumbnail
Congress Presentation
Impact of LVEF and de novo heart failure on outcomes of SGLT2 inhibitor therapy initiated during acute heart failure
thumbnail
Congress Presentation
Efficacy and safety of SGLT2 inhibitors in acute heart failure: a systematic review and meta-analysis of randomized controlled trials
thumbnail
Congress Presentation
Primary prevention of heart failure with glucagon-like peptide-1 receptor agonist

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources